1International study group for Behcet' s disease. Criteria for diagnosis of Behcet' s disease. Lancet, 1990,335 : 1078-1080.
2Mok CC, Cheng TC, Ho CT, et al. Behcet' s disease in southern chinese patients. J Rheumatol,2002,29:1689-1693.
3Kural-Seyahi E, Fresko I, Seyahi N, et al. The long-term mortality and morbility of Behcet' s syndrome. A 2-decade outcome survey of 387 patients followed at a dedicated center. Medicine,2003,82:60-67.
4Zouboulis CC, Vaiopoulos G, Marcomichelakis N. Onset signs,clinical course, prognosis, treatment and outcome of adult patients with Adamantiades-Behcet' s disease in Greece. Clin Exp Rheumatol,2003,21Suppl30 : S19-26.
5Krause I, Monselise Y, Milo G, et al, Anti-Saccharomyces cerevisiae antibodies-A novel serologic marker for Behcet' s disease, Clin Exp Rheumatol,2002,20Suppl 26 : S21-24,
6A1-Araji A, Sharquie K, A1-Rawi Z, Prevalence and patterns of neurological involvement in Behcet' s disease : a prospective study from Iraq, J Neurol Neurosurg Psychiatry,2003,74:608-613,
7Siva A, Ahintas A, Saip S, Beheet' s syndrome and the nervous system, Curr Opin Neurol,2004 ,17 :347-357.
8Siva A,Kantarci OH,Saip S,et al. Behcet' s disease: diagnostic and prognostic aspects of neurological involvement. J Neurol, 2001,248 :95-103,
9Zouboulis CC, Tumbull JR, Martus P. Univariate and multivariate analyses comparing demographic, genetic, clinical, and serological risk factors for severe Adamantiades-Behcet' s disease. Adv Exp Med Biol,2003,528 : 123-126.
